TOCENTECAN

UNII:	PL7FG32WW9
Type:	INGREDIENT SUBSTANCE
Formula:	C₄₇H₄₅FN₆O₁₇
Preferred Substance Name:	TOCENTECAN
InChIKey:	UNHOOUVLRYPIIK-VBWIOPQNSA-N
GSRS Full Record:	PL7FG32WW9 i

2763252-25-9
2-[(2-{[3-(2,5-Dihydro-2,5-dioxo-1H-pyrrol-1-yl)-1-oxopropyl]amino}acetyl)amino]-4-{[({[(1S,9S)-9-ethyl-5-fluoro-2,3,9,10,13,15-hexahydro-9-hydroxy-4-methyl-10,13-dioxo-1H,12H-benzo[de]pyrano[3′,4′:6,7]indolizino[1,2-b]quinolin-1-yl]amino}carbonyl)oxy]methyl}phenyl β-D-glucopyranosiduronic acid
C-029769
M-9140 drug-linker
M030066
M9140 drug-linker
MSC2702209D
TOCENTECAN [USAN]
Tocentecan
β-D-Glucopyranosiduronic acid, 2-[[2-[[3-(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)-1-oxopropyl]amino]acetyl]amino]-4-[[[[[(1S,9S)-9-ethyl-5-fluoro-2,3,9,10,13,15-hexahydro-9-hydroxy-4-methyl-10,13-dioxo-1H,12H-benzo[de]pyrano[3′,4′:6,7]indolizino[1,2-b]quinolin-1-yl]amino]carbonyl]oxy]methyl]phenyl

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

TOCENTECAN

Synonyms and Mappings

Resources